Insight Partners is an awesome firm that shares many of our values, and we’ve been grateful to have them as partners on this journey of building a great company based on a great product.
Eran Zinman Co-Founder & CEO Monday.com*
London, No Data Available, U.K.
Lehi, Utah, U.S.
Farmington, Utah, U.S.
San Francisco, California, U.S.
Wilmington, North Carolina, U.S.
San Francisco, California, U.S.
Limerick, No Data Available, Ireland
Amsterdam, No Data Available, Netherlands
Tel Aviv, No Data Available, Israel
Bonn, No Data Available, Germany
Miami, Florida, U.S.
San Francisco, California, U.S.
Insight Partners is an awesome firm that shares many of our values, and we’ve been grateful to have them as partners on this journey of building a great company based on a great product.
Iterative Scopes is pioneering the application of precision medicine to gastroenterology with the aim of enhancing colorectal cancer screenings. The technology is also designed to help optimize clinical trials investigating treatment of inflammatory bowel disease. Its powerful, proprietary artificial intelligence and computer vision technologies have the potential to improve the accuracy and consistency of endoscopy readings. Iterative Scopes is initially applying these advances to improve polyp detection for colorectal cancer screenings and standardizing disease severity characterization for inflammatory bowel disease (IBD). Longer term, the company plans to establish more meaningful endpoints for GI diseases, which can be better predictors of therapeutic response and disease outcomes. Spun out of MIT in 2017, the company is based in Cambridge, Massachusetts.